NASDAQ: MRNA   $0.00 VOL:   $0.00
Moderna logo

Development Programs

Respiratory Vaccines

Program
indication
Program #
Presentation
COVID-19 Vaccines: Spikevax®/mNEXSPIKE®
mRNA-1273/-1283
View PDF >
Last program update May 31, 2025
Influenza vaccine
mRNA-1010
View PDF >
Last program update May 1, 2025
RSV vaccine/mRESVIA®
mRNA-1345
View PDF >
Last program update June 12, 2025
Flu + COVID vaccine
mRNA-1083
View PDF >
Last program update May 1, 2025

Latent & Public Health Vaccines

Program
indication
Program #
Presentation
Cytomegalovirus (CMV) vaccine
mRNA-1647
View PDF >
Last program update May 1, 2025
Epstein-Barr virus (EBV) vaccine
mRNA-1189 & mRNA-1195
View PDF >
Last program update May 1, 2025
HSV vaccine
mRNA-1608
View PDF >
Last program update May 1, 2025
VZV vaccine
mRNA-1468
View PDF >
Last program update May 2, 2024
HIV vaccine
mRNA-1644 & mRNA-1547
View PDF >
Last program update May 1, 2025
Zika Vaccine
mRNA-1893
View PDF >
Last program update May 1, 2025
Nipah vaccine
mRNA-1215
View PDF >
Last program update May 1, 2025
Lyme vaccine
mRNA-1975 & mRNA-1982
View PDF >
Last program update May 1, 2025
Norovirus vaccine
mRNA-1403 & mRNA-1405
View PDF >
Last program update May 1, 2025

Therapeutics

Program
indication
Program #
Presentation
Intismeran autogene
mRNA-4157
View PDF >
Last program update May 1, 2025
Checkpoint adaptive immune modulation therapy (AIM-T)
mRNA-4359
View PDF >
Last program update May 1, 2025
PCCA/PCCB
Propionic acidemia (PA)
mRNA-3927
View PDF >
Last program update May 1, 2025
MUT
Methylmalonic acidemia (MMA)
mRNA-3705
View PDF >
Last program update May 1, 2025
G6Pase
Glycogen storage disorder type 1a (GSD1a)
mRNA-3745
View PDF >
Last program update May 1, 2025
Ornithine transcarbamylase deficiency (OTC)
mRNA-3139
View PDF >
Last program update May 1, 2025
CN-1
Crigler-Najjar Syndrome Type 1
mRNA-3351
View PDF >
Last program update May 1, 2025
Cystic Fibrosis (CF)
mRNA-3692 / VX-522
View PDF >
Last program update May 1, 2025
Share by: